Related content

Apoptosis-inducing effect of the DR5 monoclonal antibody, D-6, alone or in combination with cisplatin, on A2780 ovarian cancer cells

By          

Molecular Medicine Reports, Vol. 6, Iss. 2, 2012-01 ,pp. : 316-320

Spandidos Publications

Access to resources Recommend Favorite

Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1371-1378

Spandidos Publications

Access to resources Recommend Favorite

Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells

By        

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 425-430

Spandidos Publications

Access to resources Recommend Favorite

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

By Luo Hong  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 937-945

Springer Publishing Company

Access to resources Recommend Favorite

Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study

By Zhang Ying   Ding Jing Xin   Tao Xiang   Lu Zhi Ying   Wang Jia Jia   Feng Wei Wei   Hua Ke Qin  

Journal of Chemotherapy, Vol. 25, Iss. 2, 2013-04 ,pp. : 96-103

Maney Publishing

Access to resources Recommend Favorite